Sarepta Therma holds some great opportunities, Selling overdone.
AVERAGE ANALYSTS PRICE TARGET $190
AVERAGE ANALYSTS RECOMMENDATION BUY
HIGH 20% SHORT INTEREST.
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
AVERAGE ANALYSTS RECOMMENDATION BUY
HIGH 20% SHORT INTEREST.
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.